Your browser doesn't support javascript.
loading
Prevalence of Multidrug-Resistant Organisms in Healthy Adults in Shenzhen, China.
Liu, Ding; Li, Guiqiu; Hong, Zhifan; Zhang, Cong; Zhu, Ning; Tan, Yan; Gao, Ting.
Afiliación
  • Liu D; Ding Liu, MS, is a Senior Scientist, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.
  • Li G; Zhifan Hong is a Scientist, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.
  • Hong Z; Zhifan Hong is a Scientist, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.
  • Zhang C; Cong Zhang, MS, is a Senior Scientist, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.
  • Zhu N; Ning Zhu, PhD, is a Senior Manager, Shenzhen, People's Republic of China.
  • Tan Y; Yan Tan, PhD, is Chief Executive Officer, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.
  • Gao T; Ting Gao, PhD, is CMC Director, Shenzhen Xbiome Biotech Ltd, Shenzhen, People's Republic of China.
Health Secur ; 21(2): 122-129, 2023.
Article en En | MEDLINE | ID: mdl-36867151
ABSTRACT
Public health problems caused by the high transmission of multidrug-resistant organisms (MDROs) have attracted widespread international attention. However, studies on healthy adults in this field are scarce. In this article, we report the microbiological screening results of 180 healthy adults recruited from 1,222 participants between 2019 and 2022 in Shenzhen, China. Findings show a high MDRO carriage rate of 26.7% in those individuals who did not use any antibiotics in the past 6 months and had not been hospitalized within the past year. MDROs were mainly extended-spectrum ß-lactamase-producing Escherichia coli with high resistance to cephalosporin. With the assistance of metagenomic sequencing technology, we also performed long-term observations of several participants and found that drug-resistant gene fragments were prevalent even when MDROs were not detected by drug sensitivity testing. Based on our findings, we suggest that healthcare regulators limit the medical overuse of antibiotics and enact measures to limit its nonmedical use.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana Múltiple / Antibacterianos Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Health Secur Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacorresistencia Bacteriana Múltiple / Antibacterianos Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: Health Secur Año: 2023 Tipo del documento: Article